Related Experiment Videos
Endometrial carcinoma diagnosed by the Gynoscann method
Acta Obstetricia Et Gynecologica Scandinavica
|January 1, 1986
Summary
The Gynoscann method offers a reliable way to screen for endometrial cancer, complementing gynecological exams. This simple cytological sampling proved accurate in diagnosing endometrial carcinoma in 80% of cases.
Area of Science:
- Gynecological Oncology
- Cytopathology
Background:
- Endometrial cancer screening requires simple, reliable methods to complement standard gynecological examinations.
- Cytological sampling presents a potential non-invasive approach for early detection.
Purpose of the Study:
- To evaluate the reliability and accuracy of the Gynoscann method for endometrial cancer screening.
- To assess the correlation between Gynoscann cytology and traditional histology.
Main Methods:
- Ninety-four patients underwent Gynoscann cytological sampling prior to dilatation and curettage.
- Cytological and histological diagnoses were compared for accuracy.
Main Results:
- Ninety-six percent of cytological samples were adequate for diagnosis.
- The Gynoscann method correctly diagnosed 80% of endometrial carcinoma cases (21 out of 26).
- The method demonstrated 81% sensitivity and 100% specificity for endometrial carcinoma, with no false positives.
Conclusions:
- The Gynoscann method is a safe, easy-to-use, and reliable tool for diagnosing endometrial carcinoma.
- Further studies with larger patient cohorts are recommended to optimize sensitivity.